Transaction in Own Shares

Summary by AI ^BETAClose X

Taylor Wimpey plc has announced the purchase of 5,529,000 of its ordinary shares between May 7, 2026, and May 13, 2026, with prices ranging from 78.20 pence to 84.46 pence per share, and a volume-weighted average price of 81.59 pence. These shares are intended for cancellation, resulting in the company holding 32,050,377 shares in treasury and 3,493,833,678 shares in issue, with the total number of voting rights now standing at 3,493,833,678.

Disclaimer*

Taylor Wimpey PLC

14 May 2026

Taylor Wimpey plc

Transaction in Own Shares

Taylor Wimpey plc (the "Company") announces today that, acting through its corporate stockbroker, Citigroup Global Markets Limited (the "Broker"), it has purchased the following number of the Company's ordinary shares of 1 pence each in the period from 07 May 2026 to 13 May 2026.

Date	Number of shares purchased	Highest price paid (GBp)	Lowest price paid (GBp)	Volume weighted average price (GBp)	Trading Venue
07 May 2026	808,248	83.22	81.98	82.61	XLON
08 May 2026	643,235	84.46	82.06	83.33	XLON
11 May 2026	869,678	82.00	80.76	81.33	XLON
12 May 2026	1,502,981	81.10	79.74	80.25	XLON
13 May 2026	1,704,862	79.68	78.20	78.88	XLON

The Company intends to cancel the purchased shares.

Following the above transaction, the Company holds 32,050,377 of its ordinary shares in treasury and has 3,493,833,678 shares in issue (excluding treasury shares).

Accordingly, the total number of voting rights in the Company will be 3,493,833,678. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

http://www.rns-pdf.londonstockexchange.com/rns/2366E_1-2026-5-13.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END